Od ratowania do zapobiegania: Dostosowanie szybkiego i wczesnego zatrzymywania napadów (REST) w Radzie Współpracy Państw Zatoki Perskiej — Dowody naukowe, luki kliniczne i regionalny plan wdrożenia

Preprint (medRxiv/bioRxiv)➕ 21.11.2026Preprint (medRxiv/bioRxiv)

From Rescue to Prevention: Tailoring Rapid and Early Seizure Termination (REST) in the Gulf Cooperation Council—Evidence, Clinical Gaps, and a Regional Implementation Framework

W skrócie

[Preprint - wstępne wyniki] Artykuł analizuje, jak leczyć napady padaczki u dorosłych ludzi, aby szybko je zatrzymać, bez nadmiernego stosowania leków uspokajających. Naukowcy przejrzeli badania z krajów Zatoki Perskiej i zaproponowali nowy plan działania, który łączy indywidualny plan leczenia pacjenta, dostęp do leków i szybką pomoc. Autorzy podkreślają, że zanim będziemy pewni, czy ta metoda naprawdę zapobiega poważnym powikłaniom, konieczne są dalsze badania pilotażowe w regionie.

Oryginalny abstract (angielski)

Background: Adults with epilepsy need timely treatment of recognisable seizure emergencies without indiscriminate benzodiazepine use. Rapid and early seizure termination (REST) introduces a useful treatment objective, but consensus aspirations, product efficacy and the effectiveness of earlier intervention require separate appraisal. Objectives: To distinguish selected early seizure termination from established cluster and status-epilepticus management; map evidence and implementation gaps in Bahrain, Saudi Arabia, the United Arab Emirates, Qatar, Kuwait and Oman; and propose an auditable regional framework suitable for phased prospective evaluation across GCC countries. Methods: Six exploratory PubMed searches were supplemented by targeted publications, trial registries and official guideline and regulatory sources. Searches were rerun to 16 November 2026, with an overlapping entry-date check. Evidence was mapped by study design, therapeutic objective, population, setting, sponsorship and GCC applicability. Selection remained purposive; complete export was not equated with complete screening or formal certainty grading. Findings: Product-specific trials support community seizure-cluster treatment and professional treatment of convulsive status epilepticus. Observational timing analyses and emerging rapid-delivery studies do not establish that a universal earlier threshold prevents severe outcomes. The ILAE five-minute operational threshold, NICE’s individualised prolonged-seizure recommendations and the REST aspiration for drug action within two minutes after administration address different decisions. GCC emergency-care, awareness, education and service studies identify actionable needs but do not demonstrate adult outpatient REST effectiveness. Regional provider reports complement, without replacing, formulation-specific regulatory and dispensing verification. Conclusions: The proposed GCC framework combines clinical risk review, an individualised seizure action plan, demonstrated responder competency, verified medicine access, parallel emergency escalation and safety-balanced measurement. Phased GCC pilot studies should evaluate feasibility, acceptability and safety before comparative effectiveness research. “Prevention” denotes the intended prevention of escalation and avoidable harm; prevention of epilepsy, mortality or SUDEP is not established.

Metadane publikacji

Journal
Preprint (medRxiv/bioRxiv)
Data publikacji
18.11.2026
DOI
10.20944/preprints202611.1769.v1
Europe PMC ID
PPR1372477
Autorzy
Alsharoqi IA, Khalil A, Alsharoqi AIS, Almadani A
Źródło
Preprint (medRxiv/bioRxiv)